Eu Ivdd Eu Ivd General On The Market 🇫🇮 Finland

Actim® Partus 1ngeni Test

Actim Oy · 🇫🇮 Finland
Devices (same UDI-DI)
1
Certificates
0
Countries
5
Notified Bodies
0

Basic Information

Primary DI
D-6430030990585UL
Basic UDI-DI Code
B-6430030990585UL
Reference
31931RETAL
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market
Manufacturer
Actim Oy

Additional Description

10 test kit. Actim® Partus 1ngeni test is a qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (insulin-like growth factor binding protein-1) in cervical secretions during pregnancy. The test is read using the Actim® 1ngeni instrument. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact. A low risk test result (phIGFBP-1 concentration less than 10 µg/l) is a clear indication that the patient is not likely to deliver within 7-14 days.

CND Nomenclature Codes

Code Description
W01021699 RAPID TESTS & POINT OF CARE - IMMUNOCHEMISTRY - OTHER

Available In Countries

🇧🇪 Belgium 🇩🇪 Germany 🇫🇮 Finland 🇫🇷 France 🇮🇹 Italy

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all